When the Evidence is not Enough: Commentary on Härtel-Petri et al.

Key words

amphetamine - substance dependence disorders - dependence on drug

• References

• 1 Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P. Treatment for amphetamine dependence and abuse (Review). Cochrane Database Syst Rev 2001; 4: CD003022
• 2 Shoptaw SJ, Kao U, Ling W. Treatment for amphetamine psychosis. [Update of Cochrane Database Syst Rev. 2008; 4:CD003026]. Cochrane Database Syst Rev 2009; 1: CD003026
• 3 Perez-Mana C, Castells X, Torrens M. et al. Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database Syst Rev 2013; 9: Cd009695
• 4 Brensilver M, Heinzerling KG, Shoptaw S. Pharmacotherapy of amphetamine-type stimulant dependence: an update. Drug Alcohol Rev 2013; 32: 449-460
• 5 Brackins T, Brahm NC, Kissack JC. Treatments for methamphetamine abuse: a literature review for the clinician. J Pharm Pract 2011; 24: 541-550
• 6 Moeller FG, Schmitz JM, Herin D. et al. Use of stimulants to treat cocaine and methamphetamine abuse. Curr Psychiatry Rep 2008; 10: 385-391
• 7 Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2005; 2: 194-199
• 8 Nunes EV, Liu X, Samet S. et al. Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up. J Clin Psychiatry 2006; 67: 1561-1567
• 9 Nunes EV, Levin FR. Treating depression in substance abusers. Curr Psychiatry Rep 2006; 8: 363-370
• 10 Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Engl J Med 2003; 348: 1786-1795
• 11 Berterame S, Erthal J, Thomas J. et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 2016; 387: 1644-1656
• 12 United Nations . Office on Drugs and Crime. World Drug Report 2016. New York: United Nations; 2016